Radiotherapy and brachytherapy implant developer International Brachytherapy (IBt) of Seneffe, Belgium, has signed a distribution agreement with radioisotope manufacturer and nuclear medicine products firm Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium.
The agreement grants IBt exclusive distribution rights for IBA's Visicoil product in the U.K., Ireland, Belgium, Luxembourg, the Netherlands, and France, as well as a nonexclusive distribution right in Austria.
Visicoil is a gold marker used in image-guided radiation therapy (IGRT) procedures that can be implanted to allow more accurate targeting and higher dose deliveries, according to IBt.
By AuntMinnie.com staff writers
April 18, 2007
Related Reading
IBA increases sales and profit in 2006, March 15, 2007
IBA to install cyclotron in India, February 26, 2007
IBA expands production capacity, January 19, 2007
IBA nets U.S. proton therapy order, January 8, 2007
IsoRay, IBt notch technology agreement, January 3, 2006
Copyright © 2007 AuntMinnie.com
